Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|July 17, 1998
Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic statusD A Beauregard, P E Thelwall, D J Chaplin, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Ischaemia induced cell death in tumors: importance of temperature and pHC S Parkins, S A Hill, S J Lonergan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 miceM R Horsman, P E Kristjansen, M Mizuno, et al.
Cancer Research|May 15, 1997
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculatureG G Dark, S A Hill, V E Prise, et al.
NMR in Biomedicine|July 7, 1999
Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imagingS P Robinson, D R Collingridge, F A Howe, et al.
Oncology Reports|April 16, 1999
The effects of nicotinamide plus carbogen or pions for microscopic SCCVII tumorsA Nishioka, Y Ohizumi, G K Lam, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivoD J Honess, S A Hill, D R Collingridge, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathingM R Horsman, M Nordsmark, A A Khalil, et al.
Pageof 14